Prevalence and pathogenesis of silent myocardial ischemia following myocardial infarction. 1994

S Koyanagi, and M Aoki, and H Tashiro, and H Narabayashi, and T Inou, and A Takeshita, and M Nakamura, and M Noma, and T Tajimi, and Y Kikuchi
Research Institute of Angiocardiology, Faculty of Medicine, Kyushu University, Fukuoka, Japan.

The objective of this study was to examine the prevalence and pathogenesis of silent myocardial ischemia during exercise following myocardial infarction. Exercise-induced myocardial ischemia was assessed by 201Tl-SPECT (single photon emission computed tomography) 4.5 weeks after acute myocardial infarction in 229 patients. Exercise-induced myocardial ischemia occurred in 109 patients (48%), and 72 (32%) had silent ischemia. Although the prevalence of multivessel coronary artery disease was similar between patients with silent and symptomatic ischemia, the size of reversible myocardial ischemia was larger in patients with symptomatic ischemia than in those with silent ischemia (21.3 +/- 3.0% vs 13.2 +/- 1.9% of LV, p < 0.05). The incidence of reversible ischemia remote from the infarct area was higher in patients with symptomatic ischemia than in those with silent ischemia (30% vs 17%, p < 0.10). The cause of silent ischemia after myocardial infarction may be closely related to the smaller size of reversible myocardial ischemia. Ischemia remote from, or adjacent to, the infarct area could be a factor in determining the presence or absence of pain.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D005080 Exercise Test Controlled physical activity which is performed in order to allow assessment of physiological functions, particularly cardiovascular and pulmonary, but also aerobic capacity. Maximal (most intense) exercise is usually required but submaximal exercise is also used. Arm Ergometry Test,Bicycle Ergometry Test,Cardiopulmonary Exercise Testing,Exercise Testing,Step Test,Stress Test,Treadmill Test,Cardiopulmonary Exercise Test,EuroFit Tests,Eurofit Test Battery,European Fitness Testing Battery,Fitness Testing,Physical Fitness Testing,Arm Ergometry Tests,Bicycle Ergometry Tests,Cardiopulmonary Exercise Tests,Ergometry Test, Arm,Ergometry Test, Bicycle,Ergometry Tests, Arm,Ergometry Tests, Bicycle,EuroFit Test,Eurofit Test Batteries,Exercise Test, Cardiopulmonary,Exercise Testing, Cardiopulmonary,Exercise Tests,Exercise Tests, Cardiopulmonary,Fitness Testing, Physical,Fitness Testings,Step Tests,Stress Tests,Test Battery, Eurofit,Test, Arm Ergometry,Test, Bicycle Ergometry,Test, Cardiopulmonary Exercise,Test, EuroFit,Test, Exercise,Test, Step,Test, Stress,Test, Treadmill,Testing, Cardiopulmonary Exercise,Testing, Exercise,Testing, Fitness,Testing, Physical Fitness,Tests, Arm Ergometry,Tests, Bicycle Ergometry,Tests, Cardiopulmonary Exercise,Tests, EuroFit,Tests, Exercise,Tests, Step,Tests, Stress,Tests, Treadmill,Treadmill Tests
D005260 Female Females
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015899 Tomography, Emission-Computed, Single-Photon A method of computed tomography that uses radionuclides which emit a single photon of a given energy. The camera is rotated 180 or 360 degrees around the patient to capture images at multiple positions along the arc. The computer is then used to reconstruct the transaxial, sagittal, and coronal images from the 3-dimensional distribution of radionuclides in the organ. The advantages of SPECT are that it can be used to observe biochemical and physiological processes as well as size and volume of the organ. The disadvantage is that, unlike positron-emission tomography where the positron-electron annihilation results in the emission of 2 photons at 180 degrees from each other, SPECT requires physical collimation to line up the photons, which results in the loss of many available photons and hence degrades the image. CAT Scan, Single-Photon Emission,CT Scan, Single-Photon Emission,Radionuclide Tomography, Single-Photon Emission-Computed,SPECT,Single-Photon Emission-Computed Tomography,Tomography, Single-Photon, Emission-Computed,Single-Photon Emission CT Scan,Single-Photon Emission Computer-Assisted Tomography,Single-Photon Emission Computerized Tomography,CAT Scan, Single Photon Emission,CT Scan, Single Photon Emission,Emission-Computed Tomography, Single-Photon,Radionuclide Tomography, Single Photon Emission Computed,Single Photon Emission CT Scan,Single Photon Emission Computed Tomography,Single Photon Emission Computer Assisted Tomography,Single Photon Emission Computerized Tomography,Tomography, Single-Photon Emission-Computed
D015995 Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time. Period Prevalence,Point Prevalence,Period Prevalences,Point Prevalences,Prevalence, Period,Prevalence, Point,Prevalences

Related Publications

S Koyanagi, and M Aoki, and H Tashiro, and H Narabayashi, and T Inou, and A Takeshita, and M Nakamura, and M Noma, and T Tajimi, and Y Kikuchi
January 1986, Advances in cardiology,
S Koyanagi, and M Aoki, and H Tashiro, and H Narabayashi, and T Inou, and A Takeshita, and M Nakamura, and M Noma, and T Tajimi, and Y Kikuchi
September 1993, Clinical cardiology,
S Koyanagi, and M Aoki, and H Tashiro, and H Narabayashi, and T Inou, and A Takeshita, and M Nakamura, and M Noma, and T Tajimi, and Y Kikuchi
January 1994, Japanese circulation journal,
S Koyanagi, and M Aoki, and H Tashiro, and H Narabayashi, and T Inou, and A Takeshita, and M Nakamura, and M Noma, and T Tajimi, and Y Kikuchi
February 1987, Wisconsin medical journal,
S Koyanagi, and M Aoki, and H Tashiro, and H Narabayashi, and T Inou, and A Takeshita, and M Nakamura, and M Noma, and T Tajimi, and Y Kikuchi
August 2007, Vojnosanitetski pregled,
S Koyanagi, and M Aoki, and H Tashiro, and H Narabayashi, and T Inou, and A Takeshita, and M Nakamura, and M Noma, and T Tajimi, and Y Kikuchi
March 1992, The American journal of cardiology,
S Koyanagi, and M Aoki, and H Tashiro, and H Narabayashi, and T Inou, and A Takeshita, and M Nakamura, and M Noma, and T Tajimi, and Y Kikuchi
January 1989, Kardiologia polska,
S Koyanagi, and M Aoki, and H Tashiro, and H Narabayashi, and T Inou, and A Takeshita, and M Nakamura, and M Noma, and T Tajimi, and Y Kikuchi
September 1985, The American journal of medicine,
S Koyanagi, and M Aoki, and H Tashiro, and H Narabayashi, and T Inou, and A Takeshita, and M Nakamura, and M Noma, and T Tajimi, and Y Kikuchi
January 1988, The American journal of cardiology,
S Koyanagi, and M Aoki, and H Tashiro, and H Narabayashi, and T Inou, and A Takeshita, and M Nakamura, and M Noma, and T Tajimi, and Y Kikuchi
December 1989, Circulation,
Copied contents to your clipboard!